Relation’s Post

Last week saw our CEO, Jason Mellad, take part in a panel at LSX2024. Alongside Rosie Rodriguez PhD, Kristen Albright and João Ribas, he contributed to an important conversation on how to build inclusivity at work and why fostering diverse and interdisciplinary teams is important.   Reflecting back on the topics they discussed, Jason’s has compiled his top three takeaways. 1. Before building a team, it’s important to take time for self-reflection. Understanding yourself and what you’re bringing to the table, and understanding the gaps that you need others to fill is vital to building a well-rounded and successful team. 2. There’s plenty of research that shows more diverse teams make better decisions and perform better. So, think about how to embrace diversity in all its forms – in the language you use, in the ways you share information, in the accessibility of spaces, the places you advertise, and in an actively thinking about how to welcome and engage with people with different experiences and ways of thinking. 3. Think back to think ahead. If we want to have great talent in years to come, we need to show all young people that there are opportunities to do amazing things in our industry. So, think about engaging with schools, STEM outreach, internships etc. and show young people that the doors are open to all! A big thank you to the LSX World Congress team for the opportunity to have this big conversation! #LSX2024 #biotech #leadership #inclusion #diversity #JEDI #StartYoung #STEM #cause2cure #ThePatientIsWaiting

The key of the Change

It has been so energizing to take a break from all the heartbreaking news from Israel and spend two days focusing on innovation in the neurotech industry. Thank you JoJo Platt for the invitation to participate as a representative of Corundum Neuroscience (CNS), previously Joy Ventures, in the Neurotech Reports Neurotech Leaders Forum. It was wonderful to share perspective on neurotech investing with my fellow neurotech investors Suraj Mudichintala and Martin Dieck. This is a great meeting to gain insights from leaders in the field, hear from creative startups in the neurotech space, and have honest discussions about reimbursement challenges, how to ensure products are really benefiting patients, and how to bring a successful and high impact product to the largest number of patients. #neurotechnology #neurotech

Synthoni is TiER1's new Artificial Intelligence Accelerator! Synthoni helps clients see what's possible, show what's doable, and build what's scalable. https://hubs.li/Q02frG7_0   AI is revolutionizing how work gets done and very soon, EVERYTHING will be AI enabled. TiER1’s support will help modernize workstreams and rectify current challenges… • Improve Efficiency: Automate routine and/or error prone tasks. • Enhance Decision Making & Research: Analyze complex data, simulate experiments, identify value, and predict outcomes. • Optimize Development & Personalization: Instantly create unique content (pixels vs. images, frames vs videos, wave forms vs audio)

Save the date! 📅 On October 24th at 10:00 AM PST/ 1:00 PM ET, Element CEO and Co-founder Molly He is joining Veracyte, Inc. Co-founder and Pink Dx CEO Bonnie Anderson for an in-person fireside chat on innovation and women’s health. In this wide-ranging discussion, Molly and Bonnie share their insights on their roles as female founders and the kind of bold innovation needed for improving health. Follow us here for real-time updates -- you don’t want to miss it! #Genomics #ElemBio #BioTech #Leadership #WomenInSTEM #LifeSciences

How do CEOs of CDMOs navigate uncertainty and drive growth? Find out during the 2nd Annual Bioprocessing Venture, Innovation & Partnering Conference on August 21, 2024, in Boston, MA, part of CHI's Bioprocessing Summit. Hear from this all-star panel featuring industry leaders as they share their experiences, perspectives, and foresight on steering their organizations through dynamic and complex business landscapes to achieve sustainable growth and industry leadership. Ran Zheng (CEO, Landmark Bio) Steve Favaloro (President & CEO, Genezen) Patrick Lucy (President & CEO, RoslinCT) Rahul Singhvi (Co-Founder & CEO, Resilience) Gain insights into strategies for navigating market volatility, balancing short-term pressures with long-term goals, overcoming regulatory challenges, leveraging technology for innovation, and fostering resilience within organizations. Don’t miss this opportunity to connect with key players driving the future of bioprocessing. For more details, visit https://lnkd.in/gzryU8G2 #bioprocessing #innovation #biotech #conference #partnerships #CDMO #CEO

Whether you're in growth-mode with a healthy runway or rechannelling R&D resources toward later-stage/commercial assets, it's equally important for scaleups and enterprise environments to innovate when it comes to talent strategy - think ahead: ✨ Are your people plans realistic and underpinned by data specific to the markets you're hiring in? ✨ Can your internal leaders budget the time to attract and project-manage their own hires, or will agency spend be inevitable once plates fill up and key milestones approach? ✨ Is your EVP reflected throughout your entire interview & onboarding process? Your leadership team may know who you *want* to be as a brand, but does your team feel bought into it? ✨ Do you have the tools in-house to hire the way you want, on the timelines you need? Hiring fast in Q1 or running lean 'til Q4, lay the groundwork now, put a plan in place and challenge your muscle memory when it comes to TA - our 5 Stage Talent Audit's the perfect place to start. Ask me about it, or book a chat to talk through what's ahead for your org: https://lnkd.in/eVJHtvqE. On to 2024! 💫 Ben Rutter Lauren Peake Robert Hussey Tom Foreman Laura Affleck

🌟✨ ANNOUNCEMENT: Empowering Tomorrow's Leaders at Mikrogen! 🚀🌍 At Mikrogen, we're proud to unveil the launch of our much-anticipated Emerging Leader Program! 🌟👩🎓👨🎓 This initiative embodies our commitment to nurturing talent, fostering innovation, and propelling our incredible team toward a future with possibilities in the in vitro diagnostic industry. In an ever-evolving IVD-landscape, preparing for tomorrow's challenges means investing in our talented staff today. 🌐💡 Our Emerging Leader Program isn't just about skill development; it's about cultivating visionaries, equipping them with the tools to navigate complexities, and empowering them to drive transformative change within our industry. We believe that the motivation of our people is the cornerstone of Mikrogen's success. 🌟🌟 With this program, we're not just investing in individuals; we're investing in the future of Mikrogen, ensuring we remain at the forefront of innovation and continue to positively impact IVD in Germany and . To all our aspiring leaders stepping into this journey, remember: Your potential knows no bounds! 🚀💫 Embrace the learning opportunity, challenge the status quo, and together, let's create a future that exceeds expectations. Let's pave the way for a brighter, more innovative future in the in vitro diagnostic industry! 🎉👏 Stay tuned for more information and insights! #EmergingLeaderProgram #Mikrogen #InnovationInDiagnostics #IVD #PCR #Line #CarL #ampliCube

While I was in England, I had the delight of touring the Discovery Park after the London Biotechnology Show ended. But before I toured the facility, I interviewed Jane Kennedy, Chief Business Officer of the Discovery Park, about their facilities. From her, I learned to appreciate the finer aspects of running an innovation park, fostering collaborations, and preparing diverse biotech founders for leadership. Read further about these insights and more through the link in the comments section! #biotech #interview #innovationpark #discoverypark

The past few days at BIO-Europe have been tremendous. In Business Development, our best collaborations and deals are often born out of a strong connection and understanding of each other’s business – all the more supported by gathering in person at events like these to get to know each other, build strong relationships and discuss our priorities for the future.   And not only that, these events are also critical for personal growth. I had the opportunity to hear the latest on industry trends, science, innovations and challenges and opportunities in serving patients and delivering better outcomes, which are so important as my team and I continue to support MorphoSys’ evolution into becoming a leader in hematology-oncology.   #biotechnology #leadership #BioEurope2023